HIGHLIGHTS
- who: Ye Shen from the Department of Family Planning, Wuxi Maternity and Child Health Hospital Affiliated Nanjing Medical University, Wuxi, China have published the research: Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia, in the Journal: (JOURNAL)
SUMMARY
Endometrial hyperplasia could have some risk factors for developing endometrial carcinoma, as recent studies showed that in certain women, endometrial hyperplasia significantly increases the risk of developing endometrial cancer later. The options of treatment for endometrial hyperplasia depend on the subtypes of endometrial hyperplasia . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.